| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 10/11/1989 | EP0336324A1 Process for treating insoluble fused heterogenic protein |
| 10/10/1989 | US4873188 Method, monoclonal antibody, and monoclonal antibody fragments for detecting human non-small cell lung carcinomas and cell line for producing such antibodies |
| 10/05/1989 | WO1989009403A1 Diagnostic methods and systems for quantifying apo ai |
| 10/05/1989 | WO1989009286A1 PROTAMINE-REACTIVE IgM ANTIBODIES |
| 10/05/1989 | WO1989009260A1 Ryegrass pollen allergen |
| 10/05/1989 | WO1989009064A1 Synthetic peptides from streptococcal m protein and vaccines prepared therefrom |
| 10/03/1989 | US4871670 Dna transfer vector |
| 10/03/1989 | US4871659 Reagent for detecting non-A, non-B viral hepatitis (NANBH) and an immunoenzymatic method for detecting NANBH antigens in fecal extracts |
| 09/26/1989 | CA1260858A1 Expression using fused genes providing for protein product |
| 09/26/1989 | CA1259920A1 Immunotoxin and method of making |
| 09/21/1989 | WO1989008843A1 Process for preparation of high molecular weight cell-associated protein of campylobacter pylori and use for serological detection of campylobacter pylori infection |
| 09/21/1989 | WO1989008662A1 General cancer-associated scm-recognition factor, preparation and method of use |
| 09/20/1989 | EP0333691A2 A recombinant fusion protein, its use and a recombinant vector |
| 09/20/1989 | EP0333517A2 Method and agent for inhibiting the binding of human polymorphonuclear leukocytes to endothelium and compositions therefor |
| 09/20/1989 | EP0332677A1 Attenuated herpes viruses, herpes viruses which include foreign dna encoding an amino acid sequence and vaccines containing same |
| 09/20/1989 | EP0332660A1 Bioadhesives |
| 09/20/1989 | EP0332640A1 Recombinant alzheimer's amyloid protein |
| 09/20/1989 | CN1035679A Nanbv diagnostics and vaccines |
| 09/19/1989 | EP0232255A4 Immunochemical assays for human amylase isoenzymes and related monoclonal antibodies, hybridoma cell lines and production thereof. |
| 09/13/1989 | EP0332225A2 Antibody to polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor |
| 09/13/1989 | EP0332174A2 Cell specific cytotoxic agents |
| 09/13/1989 | EP0331961A2 Method for protein synthesis using CKS fusion proteins |
| 09/13/1989 | CN1035526A Vectors and compounds for expression of zymogen forms of human protein c |
| 09/08/1989 | WO1989008130A1 Immobilized artificial membranes |
| 09/08/1989 | WO1989008118A1 Synthetic scm-active cancer recognition peptides |
| 09/06/1989 | EP0330725A1 Preparation and expression of DNA sequences coding for proteins having the biological properties of cystatin C |
| 08/30/1989 | EP0329994A1 Immunogen and its use in preparing antibodies to haemoglobin A1C |
| 08/30/1989 | EP0329761A1 Hiv-1-related polypeptides, diagnostic systems and assay methods |
| 08/30/1989 | EP0329755A1 Recombinant antibody and method |
| 08/29/1989 | US4861581 Detection of necrotic malignant tissue and associated therapy |
| 08/24/1989 | WO1989007650A1 Cloned genes coding for avian coccidiosis antigens which induce a cell-mediated response and method of producing the same |
| 08/24/1989 | WO1989007452A1 Improvements in or relating to antibodies |
| 08/24/1989 | WO1989006974A3 T-cell epitope as carriers molecule for conjugate vaccines |
| 08/23/1989 | EP0329622A2 Method of cleavage at methionine of polypeptides |
| 08/23/1989 | EP0329175A1 Human nerve growth factor gene segment |
| 08/23/1989 | EP0329127A2 Novel, signal peptides capable of functioning in yeasts and secretory expression of heterologous proteins using same |
| 08/22/1989 | US4859609 Binding ligand to polypeptide |
| 08/16/1989 | EP0328404A1 Modified antibodies |
| 08/16/1989 | EP0328403A2 Synthetic peptides related to the HIV-GP120-env-protein, and their use |
| 08/16/1989 | EP0328253A2 DNA sequences coding for avian coccidiosis antigens which induce a cell-mediated response, methods for their production, and vaccines containing them |
| 08/16/1989 | EP0327939A2 Method for the cleavage of fusion protein |
| 08/15/1989 | US4857474 Phycoerythrins useful in fluorescent conjugates |
| 08/10/1989 | WO1989007142A1 Domain-modified constant region antibodies |
| 08/10/1989 | WO1989006974A2 T-cell epitope as carriers molecule for conjugate vaccines |
| 08/10/1989 | WO1989006972A1 Preparation of a recombinant subunit vaccine against pseudorabies infection |
| 08/10/1989 | WO1989006968A1 Therapeutic use of anti-t cell immunotoxin for autoimmune diseases |
| 08/10/1989 | WO1989006967A1 Immunosupression with anti-pan t-cell immunotoxin compositions |
| 08/09/1989 | EP0327418A1 Immunometic method for the determination of lipoprotein particles monocloned antibodies agent Lp(a) and their use for the diagnosis of atherosclerosis |
| 08/09/1989 | EP0327378A1 Domain-modified constant region antibodies |
| 08/09/1989 | EP0327305A2 Preparation of a recombinant subunit vaccine against pseudorabies infection |
| 08/09/1989 | EP0327169A2 Immunotoxins from barley toxin |
| 08/09/1989 | EP0327070A1 Fluorocarbon chain-containing antigenic conjugates |
| 08/09/1989 | CN1034581A Antigen-antibody conjugate |
| 08/08/1989 | US4855406 Oncogene-related peptides |
| 08/02/1989 | EP0326120A2 Human IFN-beta2/IL-6, its purification and uses |
| 08/02/1989 | EP0326073A1 Haptene protein conjugates and their use |
| 08/02/1989 | EP0326013A2 Novel proteins derived from human alpha2-plasmin inhibitor or proteins similar thereto |
| 08/02/1989 | EP0325849A2 Retinoic acid receptor composition and method for identifying ligands |
| 08/02/1989 | EP0325639A1 Fibrin-binding compound and method |
| 07/27/1989 | WO1989006692A1 Method of treating tumor cells by inhibiting growth factor receptor function |
| 07/27/1989 | WO1989006690A1 Cloned genes encoding ig-cd4 fusion proteins and the use thereof |
| 07/27/1989 | WO1989006543A1 Htlv-i peptide antigen and assay |
| 07/26/1989 | EP0325262A2 Cloned genes encoding IG-CD4 fusion proteins and the use thereof |
| 07/26/1989 | EP0325224A2 Methods of producing secreted receptor analogs and biologically active peptide dimers. |
| 07/26/1989 | EP0324789A1 Methods of regulating metabolic stability of proteins |
| 07/26/1989 | CN1034208A Process for the prepn. of peptide structures and immunogens containing them useful in the control of fertility |
| 07/25/1989 | US4851341 Forming protein-monoclonal antibody complex, isolation, dissociating |
| 07/19/1989 | EP0324648A2 Recombinant eimeria tenella vaccines |
| 07/19/1989 | EP0324625A1 Antigen antibody conjugate |
| 07/19/1989 | EP0324162A1 Method of producing antibodies by genetic engineering |
| 07/18/1989 | US4849509 Hybridomas |
| 07/13/1989 | WO1989006240A1 Peptide corresponding to hiv-env 583-599, and analogs thereof and applications of the peptides |
| 07/13/1989 | WO1989006138A1 UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES |
| 07/12/1989 | EP0323806A1 Novel chimeric antibodies |
| 07/12/1989 | EP0323769A1 Peptide structures, immunogens containing them, and their use in the control of fertility |
| 07/11/1989 | US4847080 Genetic engineering |
| 07/05/1989 | EP0323424A2 Peptide corresponding to HIV-env 583-599, and analogs thereof and applications of the peptides |
| 07/05/1989 | EP0323149A2 Vectors and compounds for expression of zymogen forms of human protein C |
| 07/05/1989 | EP0322990A1 Polypeptides and derivatives thereof as well as their use in pharmaceutical and diagnostic compositions |
| 07/05/1989 | EP0322712A2 DNA sequences specific for malaria, their expression products and applications thereof |
| 07/04/1989 | US4845197 Monoclonal antibodies and methods for fungal pathogen detection |
| 07/04/1989 | US4845026 Medical diagnosis and monitoring |
| 07/04/1989 | CA1256795A1 Anti-idiotype antibodies induced by synthetic polypeptides |
| 06/29/1989 | WO1989005857A1 A METHOD OF SIMULTANEOUSLY PRODUCING A LARGE NUMBER OF Leu17-VIP-ANALOGS AND NEW Leu17-VIP-ANALOGS |
| 06/29/1989 | WO1989005816A1 Cellular toxic conjugates |
| 06/29/1989 | WO1989005658A1 Proteins and process for preparing them, dna sequences, antibodies and their application, poxvirus, transformed or infected cells and pharmaceutical compositions useful for preventing toxoplasmosis |
| 06/28/1989 | EP0322394A2 Expression of HIV proteins in E. coli and S. cerevisiae |
| 06/28/1989 | EP0322115A2 Genetic detoxification of pertussis toxin |
| 06/28/1989 | EP0321546A1 Immunoassay for aromatic ring containing compounds |
| 06/27/1989 | US4842999 Canine heartworm vaccine and diagnostic test |
| 06/20/1989 | US4840897 Des(b30)insulin bonded to removable amino acid or di- or tripeptide group |
| 06/20/1989 | US4840895 Monoclonal antibodies reactive with immune complexes |
| 06/20/1989 | US4840894 Using protein antibody complex |
| 06/15/1989 | WO1989005355A1 Retinoic acid receptor composition and method |
| 06/15/1989 | WO1989005307A1 Sf-25 colon adenocarcinoma antigen, and antibodies which recognize this antigen |
| 06/07/1989 | EP0318580A1 Preparation of novel protein sweeteners |
| 06/01/1989 | WO1989004873A1 Production of gonorrheal pi proteins and vaccines |
| 06/01/1989 | WO1989004839A1 Improved ricin molecules and ricin toxin conjugates |
| 06/01/1989 | WO1989004669A1 Nanbv diagnostics and vaccines |
| 05/31/1989 | EP0318216A1 NANBV diagnostics and vaccines |